<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Raised platelets / thrombocytosis — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Raised platelets / thrombocytosis</h1>
        <div class="sub">Evidence summary (key statements + how they fit together) → DGRefHelp first draft (D&amp;G).</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑12</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key decision points to build the page around</strong>
                <ul>
                  <li><strong>Confirm it’s real + persistent</strong>: recheck platelets (and review previous FBCs). Most thrombocytosis is reactive and may settle over 4–8 weeks.</li>
                  <li><strong>Don’t miss cancer</strong>: thrombocytosis is a risk marker for malignancy (esp “LEGO‑C”: lung, endometrial, gastric, oesophageal, colorectal). If <strong>unexplained</strong>, assess for tumour-specific symptoms and use the matching USC pathway.</li>
                  <li><strong>If no tumour-specific symptoms</strong>: both NICE NG12 and Scottish Referral Guidelines highlight <strong>urgent chest X‑ray</strong> as the default investigation for people ≥40 with thrombocytosis (and consider broader imaging/RCDS if systemic symptoms or gut feeling).</li>
                </ul>
              </div>

              <h4>1) Scottish Referral Guidelines for Suspected Cancer (SRG) 2025 — thrombocytosis box</h4>
              <ul>
                <li>SRG emphasises thrombocytosis is usually reactive but can reflect malignancy; highlights LEGO‑C cancers (lung, endometrial, gastric, oesophageal, colorectal).</li>
                <li>If <strong>unexplained thrombocytosis</strong> is identified: assess for cancer symptoms/signs and refer to <strong>tumour-specific USC</strong> if appropriate.</li>
                <li>If unexplained thrombocytosis with <strong>no tumour-specific symptoms</strong>: SRG recommends arranging a <strong>chest X‑ray</strong>.</li>
                <li>If unexplained thrombocytosis plus <strong>non-specific symptoms</strong> (e.g. significant weight loss) or GP “gut feeling”: consider referral for further investigation via <strong>rapid cancer diagnostic service</strong> (where available) or GP direct access imaging pathways.</li>
              </ul>

              <h4>2) NICE NG12 — where thrombocytosis changes action</h4>
              <div class="callout">
                <strong>Lung cancer (NG12):</strong>
                <ul>
                  <li>Consider an <strong>urgent chest X‑ray (within 2 weeks)</strong> in people aged ≥40 with <strong>thrombocytosis</strong>.</li>
                </ul>
              </div>

              <div class="callout">
                <strong>Upper GI cancer (NG12):</strong>
                <ul>
                  <li>Consider <strong>non‑urgent direct-access upper GI endoscopy</strong> in people aged ≥55 with <strong>raised platelets</strong> and upper GI symptoms such as nausea/vomiting/weight loss/reflux/dyspepsia/upper abdominal pain.</li>
                </ul>
              </div>

              <div class="callout">
                <strong>Endometrial cancer (NG12):</strong>
                <ul>
                  <li>Consider <strong>direct-access ultrasound</strong> for women aged ≥55 with unexplained vaginal discharge who have <strong>thrombocytosis</strong> (among other triggers).</li>
                </ul>
              </div>

              <h4>3) Haematology referral thresholds (example: NHS Lothian RefHelp)</h4>
              <ul>
                <li>RefHelp (not D&amp;G) suggests haematology referral for: <strong>persistent unexplained platelets &gt;450×10<sup>9</sup>/L for ≥3 months</strong>, or <strong>acute arterial/venous occlusive event</strong> with platelets &gt;450×10<sup>9</sup>/L.</li>
                <li>Lists a pragmatic primary care workup: serial FBCs, blood film, inflammatory markers (CRP/ESR), ferritin, U&amp;Es, LFTs, LDH; and reminds reactive thrombocytosis can take 4–8 weeks to resolve.</li>
                <li><strong>Implication for D&amp;G DGRefHelp:</strong> include a simple, “do-this-first” baseline workup + clear triggers for (a) USC/tumour-specific referral and (b) haematology referral for persistent unexplained thrombocytosis.</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed (drafting-site only)</strong>
                <ul>
                  <li>Confirm D&amp;G default for <strong>unexplained thrombocytosis with no tumour-specific symptoms</strong>: urgent CXR via which ordering route? (direct access vs via local USC pathway).</li>
                  <li>Confirm whether D&amp;G has access to a <strong>Rapid Cancer Diagnostic Service (RCDS)</strong> or a defined “non-specific symptoms” cancer pathway.</li>
                  <li>Confirm haematology referral threshold/wording for D&amp;G (e.g. persistent &gt;450 for ≥3 months; urgent threshold if &gt;1000; what to do if thrombosis).</li>
                  <li>Confirm whether JAK2/MPL/CALR testing is done in primary care or only after haematology triage.</li>
                </ul>
              </div>

              <div class="small">This evidence summary is written for pathway design: it highlights only decision‑changing points and where local policy choices sit.</div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
  &lt;li&gt;Thrombocytosis = raised platelet count. Most cases in primary care are &lt;strong&gt;reactive&lt;/strong&gt; (infection/inflammation, iron deficiency/bleeding, recent surgery, malignancy, hyposplenism).&lt;/li&gt;
  &lt;li&gt;Important “can’t miss” possibilities: &lt;strong&gt;(1) cancer&lt;/strong&gt; and &lt;strong&gt;(2) myeloproliferative neoplasm (MPN)&lt;/strong&gt; (e.g. essential thrombocythaemia).&lt;/li&gt;
  &lt;li&gt;Unexplained thrombocytosis is a risk marker for malignancy (esp “LEGO‑C”: lung, endometrial, gastric, oesophageal, colorectal) — assess for tumour-specific symptoms and route appropriately.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Confirm it’s real + persistent:&lt;/strong&gt; check previous FBCs; repeat FBC if new finding.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Look for reactive causes:&lt;/strong&gt; recent infection/inflammation, recent surgery/trauma, bleeding, iron deficiency, chronic inflammatory disease, hyposplenism, malignancy (and medications if relevant).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Screen for cancer symptoms (LEGO‑C):&lt;/strong&gt; cough/SOB/chest pain/weight loss; dyspepsia/upper abdominal pain/reflux/vomiting; change in bowel habit/PR bleeding/abdominal pain; postmenopausal bleeding/vaginal discharge; systemic symptoms (fatigue, anorexia, night sweats).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Examination:&lt;/strong&gt; chest; abdominal mass/hepatosplenomegaly; lymph nodes; signs of chronic inflammation.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Baseline tests (suggested set):&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Repeat FBC + blood film.&lt;/li&gt;
      &lt;li&gt;Ferritin (± iron studies if needed).&lt;/li&gt;
      &lt;li&gt;CRP (± ESR).&lt;/li&gt;
      &lt;li&gt;U&amp;amp;Es, LFTs (ALP may increase cancer risk when elevated alongside thrombocytosis).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Treat likely reactive causes&lt;/strong&gt; (e.g. iron deficiency, infection/inflammation) and &lt;strong&gt;recheck platelets&lt;/strong&gt;: reactive thrombocytosis may take &lt;strong&gt;4–8 weeks&lt;/strong&gt; to settle.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;If unexplained thrombocytosis:&lt;/strong&gt;
    &lt;ul&gt;
      &lt;li&gt;Assess for tumour-specific symptoms and use the matching USC pathway.&lt;/li&gt;
      &lt;li&gt;If no tumour-specific symptoms: arrange an &lt;strong&gt;urgent chest X‑ray (within 2 weeks)&lt;/strong&gt; (NG12).&lt;/li&gt;
      &lt;li&gt;If non-specific systemic symptoms (e.g. significant weight loss) or “gut feeling”: consider rapid cancer diagnostic / direct access imaging pathway (where available).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Safety‑net:&lt;/strong&gt; document plan for repeat counts and review; advise to re-present if new cancer symptoms develop or symptoms persist/worsen.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;p&gt;Use tumour-specific USC routes where possible, and include relevant results (serial platelet counts + ferritin/CRP/LFTs + CXR if done).&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Tumour-specific suspected cancer pathway (USC)&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Refer USC&lt;/strong&gt; if thrombocytosis is accompanied by symptoms/signs consistent with a specific cancer site (use NG12/SRG criteria).&lt;/li&gt;
  &lt;li&gt;Example NG12 triggers that use thrombocytosis:&lt;/li&gt;
  &lt;li&gt;
    &lt;ul&gt;
      &lt;li&gt;Age ≥40 with thrombocytosis → consider urgent chest X‑ray within 2 weeks (lung cancer assessment).&lt;/li&gt;
      &lt;li&gt;Age ≥55 with raised platelets + upper GI symptoms → consider direct-access upper GI endoscopy.&lt;/li&gt;
      &lt;li&gt;Women ≥55 with unexplained vaginal discharge + thrombocytosis → consider direct-access pelvic ultrasound (endometrial cancer assessment).&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;&lt;strong&gt;Haematology&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;&lt;strong&gt;Refer haematology&lt;/strong&gt; for &lt;strong&gt;persistent unexplained thrombocytosis&lt;/strong&gt; (e.g. &amp;gt;450×10&lt;sup&gt;9&lt;/sup&gt;/L for &amp;ge;3 months) after reactive causes addressed/excluded.&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Refer urgently / same-day advice&lt;/strong&gt; if very high platelets (local threshold) or clinical concern for thrombosis/bleeding, or features suggesting an MPN (splenomegaly, erythrocytosis/leucocytosis, constitutional symptoms).&lt;/li&gt;
  &lt;li&gt;&lt;strong&gt;Route (draft placeholder):&lt;/strong&gt; SCI Gateway → DGRI → Haematology (Advice/Outpatients).&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;
  &lt;li&gt;Single raised platelet count that normalises on repeat testing.&lt;/li&gt;
  &lt;li&gt;Clear reactive thrombocytosis with an identified cause (e.g. infection/inflammation, iron deficiency) that is being treated — recheck to confirm down-trend.&lt;/li&gt;
&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;
  &lt;li&gt;NICE NG12: Suspected cancer — recommendations organised by site of cancer (lung: thrombocytosis → urgent CXR; upper GI: raised platelets + symptoms → consider endoscopy; endometrial: discharge + thrombocytosis → consider ultrasound). https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer (retrieved 2026‑02‑12)&lt;/li&gt;
  &lt;li&gt;Scottish Referral Guidelines for Suspected Cancer 2025 (thrombocytosis section; LEGO‑C; unexplained thrombocytosis → assess symptoms; if none, arrange CXR; consider RCDS/direct imaging for non-specific symptoms). https://www.gov.scot/publications/scottish-referral-guidelines-suspected-cancer-2025/pages/3/ (retrieved 2026‑02‑12)&lt;/li&gt;
  &lt;li&gt;NHS Lothian RefHelp: Thrombocytosis (example haematology referral threshold: persistent unexplained &amp;gt;450×10&lt;sup&gt;9&lt;/sup&gt;/L for ≥3 months; suggested baseline tests). https://apps.nhslothian.scot/refhelp/guidelines/haematology/thrombocytosis/ (retrieved 2026‑02‑12)&lt;/li&gt;
&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
              <h3>Raised platelets / thrombocytosis</h3>

              <h4>Background</h4>
              <ul>
                <li>Thrombocytosis = raised platelet count. Most cases in primary care are <strong>reactive</strong> (infection/inflammation, iron deficiency/bleeding, recent surgery, malignancy, hyposplenism).</li>
                <li>Important “can’t miss” possibilities: <strong>(1) cancer</strong> and <strong>(2) myeloproliferative neoplasm (MPN)</strong> (e.g. essential thrombocythaemia).</li>
                <li>Unexplained thrombocytosis is a risk marker for malignancy (esp “LEGO‑C”: lung, endometrial, gastric, oesophageal, colorectal) — assess for tumour-specific symptoms and route appropriately.</li>
              </ul>

              <h4>Assessment (primary care) — collapsible</h4>
              <ul>
                <li><strong>Confirm it’s real + persistent:</strong> check previous FBCs; repeat FBC if new finding.</li>
                <li><strong>Look for reactive causes:</strong> recent infection/inflammation, recent surgery/trauma, bleeding, iron deficiency, chronic inflammatory disease, hyposplenism, malignancy.</li>
                <li><strong>Screen for cancer symptoms (LEGO‑C):</strong> cough/SOB/chest pain/weight loss; dyspepsia/upper abdominal pain/reflux/vomiting; change in bowel habit/PR bleeding/abdominal pain; postmenopausal bleeding/vaginal discharge; systemic symptoms (fatigue, anorexia, night sweats).</li>
                <li><strong>Examination:</strong> chest; abdominal mass/hepatosplenomegaly; lymph nodes; signs of chronic inflammation.</li>
                <li><strong>Baseline tests (suggested set):</strong>
                  <ul>
                    <li>Repeat FBC + blood film.</li>
                    <li>Ferritin (± iron studies if needed).</li>
                    <li>CRP (± ESR).</li>
                    <li>U&amp;Es, LFTs (ALP may increase cancer risk when elevated alongside thrombocytosis).</li>
                  </ul>
                </li>
              </ul>

              <h4>Primary care management</h4>
              <ul>
                <li><strong>Treat likely reactive causes</strong> (e.g. iron deficiency, infection/inflammation) and <strong>recheck platelets</strong>: reactive thrombocytosis may take <strong>4–8 weeks</strong> to settle.</li>
                <li><strong>If unexplained thrombocytosis:</strong>
                  <ul>
                    <li>Assess for tumour-specific symptoms and use the matching USC pathway.</li>
                    <li>If no tumour-specific symptoms: arrange an <strong>urgent chest X‑ray (within 2 weeks)</strong> (NG12/SRG default).</li>
                    <li>If non-specific systemic symptoms (e.g. significant weight loss) or “gut feeling”: consider rapid cancer diagnostic / direct access imaging pathway (where available).</li>
                  </ul>
                </li>
                <li><strong>Safety‑net:</strong> document plan for repeat counts and review; advise to re-present if new cancer symptoms develop or symptoms persist/worsen.</li>
              </ul>

              <h4>Who to refer</h4>
              <p class="small">Use tumour-specific USC routes where possible, and include relevant results (serial platelet counts + ferritin/CRP/LFTs + CXR if done).</p>

              <h4>Tumour-specific suspected cancer pathway (USC)</h4>
              <ul>
                <li><strong>Refer USC</strong> if thrombocytosis is accompanied by symptoms/signs consistent with a specific cancer site (use NG12/SRG criteria).</li>
                <li><strong>NG12 examples where thrombocytosis changes action:</strong>
                  <ul>
                    <li>Age ≥40 with thrombocytosis → consider urgent chest X‑ray within 2 weeks (lung cancer assessment).</li>
                    <li>Age ≥55 with raised platelets + upper GI symptoms → consider direct-access upper GI endoscopy.</li>
                    <li>Women ≥55 with unexplained vaginal discharge + thrombocytosis → consider direct-access pelvic ultrasound.</li>
                  </ul>
                </li>
              </ul>

              <h4>Haematology</h4>
              <ul>
                <li><strong>Refer haematology</strong> for <strong>persistent unexplained thrombocytosis</strong> (e.g. &gt;450×10<sup>9</sup>/L for ≥3 months) after reactive causes addressed/excluded.</li>
                <li><strong>Refer urgently / same-day advice</strong> if very high platelets (local threshold) or clinical concern for thrombosis/bleeding, or features suggesting an MPN (splenomegaly, erythrocytosis/leucocytosis, constitutional symptoms).</li>
                <li><strong>Route (draft placeholder):</strong> SCI Gateway → DGRI → Haematology (Advice/Outpatients).</li>
              </ul>

              <h4>Who not to refer</h4>
              <ul>
                <li>Single raised platelet count that normalises on repeat testing.</li>
                <li>Clear reactive thrombocytosis with an identified cause (e.g. infection/inflammation, iron deficiency) that is being treated — recheck to confirm down-trend.</li>
              </ul>

              <h4>Local agreement needed (drafting-site only)</h4>
              <ul>
                <li><label><input type="checkbox" disabled /> Confirm D&amp;G default for <strong>unexplained thrombocytosis with no tumour-specific symptoms</strong>: urgent CXR via which route (direct access vs USC pathway) and how to order.</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether D&amp;G has access to a <strong>Rapid Cancer Diagnostic Service (RCDS)</strong> / non-specific symptoms cancer pathway (and referral route).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm haematology referral threshold/wording for D&amp;G (e.g. persistent &gt;450 for ≥3 months; urgent threshold if &gt;1000; what to do if thrombosis).</label></li>
                <li><label><input type="checkbox" disabled /> Confirm whether JAK2/MPL/CALR testing is done in primary care or only after haematology triage.</label></li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑12)</h3>
              <ol>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (lung: thrombocytosis → urgent CXR; upper GI: raised platelets + symptoms → consider endoscopy; endometrial: discharge + thrombocytosis → consider ultrasound). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Scottish Referral Guidelines for Suspected Cancer 2025 (thrombocytosis section; LEGO‑C; unexplained thrombocytosis → assess symptoms; if none, arrange CXR; consider RCDS/direct imaging for non-specific symptoms). <a href="https://www.gov.scot/publications/scottish-referral-guidelines-suspected-cancer-2025/pages/3/">gov.scot</a></li>
                <li>NHS Lothian RefHelp: Thrombocytosis (example haematology referral threshold and baseline tests; not D&amp;G). <a href="https://apps.nhslothian.scot/refhelp/guidelines/haematology/thrombocytosis/">apps.nhslothian.scot</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
